glp-1 and macular degeneration Drugs Linked to Small but Worrying Increase in Wet AMD Risk An estimated 6-10% of Americans

2020 Jan 6;: PMID: 31561944

GLP-1 RA therapy reduces the risk of incident atrial fibrillation by 46% in patients with HFpEF and HFmrEF while also improving weight, blood pressure, and left atrial remodeling

Types of Injections and Recommended Needle Sizes Understanding the purpose of each injection type is key to choosing the correct needle gauge and length

A comprehensive pre-treatment panel typically includes a Complete Metabolic Panel (CMP) to assess liver and kidney function, a Complete Blood Count (CBC), thyroid function tests (TSH, Free T3, Free T4), fasting glucose and insulin levels, HbA1c, and a lipid panel

Last reviewed: July 6, 2026 Last updated: July 6, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

Semaglutide does not compromise blood quality or change donation eligibility based on test results